[go: up one dir, main page]

BR9807980A - Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva - Google Patents

Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva

Info

Publication number
BR9807980A
BR9807980A BR9807980-8A BR9807980A BR9807980A BR 9807980 A BR9807980 A BR 9807980A BR 9807980 A BR9807980 A BR 9807980A BR 9807980 A BR9807980 A BR 9807980A
Authority
BR
Brazil
Prior art keywords
compound
mammal
breflato
treat
cognitive impairment
Prior art date
Application number
BR9807980-8A
Other languages
English (en)
Inventor
Richard L Gabriel
Original Assignee
Allelix Pharm Eco L P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Pharm Eco L P filed Critical Allelix Pharm Eco L P
Publication of BR9807980A publication Critical patent/BR9807980A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

"USO DE UM COMPOSTO E COMPOSTO PARA TRATAR DE MAMìFERO COM DISFUNçãO COGNITIVA". Descritos estão métodos para tratar um mamífero sofrendo de disfunção cognitiva. O método compreende administrar uma quantidade terapeuticamente efetiva de Breflato ou de um derivado de Breflato, como descrito aqui. Também descritos estão métodos para melhorar funções cognitivas em um mamífero. O método compreende administrar uma quantidade intensificadora cognitiva efetiva de Breflato ou de um derivado de Breflato, como descrito aqui.
BR9807980-8A 1997-02-05 1998-02-04 Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva BR9807980A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3688997P 1997-02-05 1997-02-05
PCT/US1998/002009 WO1998033498A1 (en) 1997-02-05 1998-02-04 Drugs for memory enhancement

Publications (1)

Publication Number Publication Date
BR9807980A true BR9807980A (pt) 2000-03-28

Family

ID=21891226

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807980-8A BR9807980A (pt) 1997-02-05 1998-02-04 Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva

Country Status (6)

Country Link
EP (1) EP0969830A1 (pt)
JP (1) JP2001512422A (pt)
AU (1) AU6141798A (pt)
BR (1) BR9807980A (pt)
CA (1) CA2279947A1 (pt)
WO (1) WO1998033498A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531477A (en) * 2001-08-31 2006-10-27 Corcept Therapeutics Inc Use of a glucocorticoid receptor antagonist comprising a steroidal skeleton with at least one phenyl-containing moiety in the 11-beta position of the steroidal skeleton to decrease cognitive deterioration in adults with Down's syndrome
WO2010068173A1 (en) 2008-12-12 2010-06-17 Daniel Klamer L-lysine for improving normal cognitive functions
CN112851622B (zh) * 2019-11-28 2023-01-10 中国海洋大学 一种大环内酯布雷菲德菌素a酯类衍生物及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
US5696154A (en) * 1994-06-29 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Brefeldin A derivatives and their utility in the treatment of cancer
AU703667B2 (en) * 1994-09-20 1999-04-01 Regents Of The University Of California, The Drugs to improve synaptic transmission
US5618837A (en) * 1995-06-07 1997-04-08 Zymogenetics, Inc. PDGF antagonists III

Also Published As

Publication number Publication date
CA2279947A1 (en) 1998-08-06
AU6141798A (en) 1998-08-25
JP2001512422A (ja) 2001-08-21
WO1998033498A1 (en) 1998-08-06
EP0969830A1 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
BR9811012A (pt) "uso de um composto".
ATE249421T1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
EA199800667A1 (ru) Новые фенантридины
EA199900324A1 (ru) Комбинированная терапия для лечения психозов
AU2207000A (en) Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
EP0969720A4 (en) COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN NEOPLASM TREATMENT
BR9808221A (pt) Método de tratamento de tumor.
AU1711197A (en) Method for treating sexual dysfunctions
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
BR9807980A (pt) Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
BR9708525A (pt) Método de tratamento de insuficência cardíaca com antagonistas de endotelina
DE69534753D1 (de) Nierenpolycystose-gen
EP0971725A4 (en) METHOD FOR TREATING SCAR TISSUE
TR200001715T2 (tr) Potasyum kanalı açıcıları.
EA199800819A1 (ru) Способ лечения биполярного расстройства
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired